Sodium Stibogluconate is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Not FDA approved in the U.S.
- Available from the CDC for under an IND protocol: http://www.cdc.gov…
- CDC’s IND protocol covers IV and IM administration (not intralesional).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Cutaneous, visceral, and mucosal leishmaniasis
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: May 30, 2016
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sodium Stibogluconate
ID - 540510
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2016/05/30/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540510/all/Sodium_Stibogluconate
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -